Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: dose constraints to virtual volumes or to organs at risk?

MLA

Ghalibafian, Mithra, et al. “Heart and Coronary Artery Protection in Patients with Mediastinal Hodgkin Lymphoma Treated with Intensity-Modulated Radiotherapy: Dose Constraints to Virtual Volumes or to Organs at Risk?” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 87, no. 1, Apr. 2008, pp. 82–88. EBSCOhost, https://doi.org/10.1016/j.radonc.2007.10.016.

APA

Ghalibafian, M., Beaudre, A., & Girinsky, T. (2008). Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: dose constraints to virtual volumes or to organs at risk? Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 87(1), 82–88. https://doi.org/10.1016/j.radonc.2007.10.016

Chicago

Ghalibafian, Mithra, Anne Beaudre, and Theodore Girinsky. 2008. “Heart and Coronary Artery Protection in Patients with Mediastinal Hodgkin Lymphoma Treated with Intensity-Modulated Radiotherapy: Dose Constraints to Virtual Volumes or to Organs at Risk?” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 87 (1): 82–88. doi:10.1016/j.radonc.2007.10.016.